Status: Recruiting
Universal CAR-T Cells Targeting Multiple Myeloma
The aim of this study is to assess the feasibility, safety and efficacy of universal CAR T cells targeting multiple myeloma. Another goal of the study is to learn more about the persistence and function of the universal CAR T cells in the body.
Participants needed: 20
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Shenzhen Geno-Immune Medical InstituteUpdated: Jun 23, 2026Locations: 1
Eligibility criteria
Patients with confirmed multiple myeloma failed curative treatment options (incl... [+10]
Pregnant or lactating women [+6]